Articles about leen kawas

Investor who called for ouster of Athira Pharma CEO suspends campaign

The activist shareholder behind an attempt to replace the CEO of Athira Pharma has suspended his campaign. Billionaire Richard (Ric)… Read More

Former Athira Pharma exec says company fell below ‘scientific ethics’ in handling of ex-CEO

The former head of clinical development and research at Athira Pharma criticized the company’s handling of an investigation that led… Read More

Latest life sciences news: COVID-19 nasal spray; disease reversal; Amazon’s healthcare priorities

This week we highlighted the finalists for Health Innovation of the Year at the GeekWire Awards. The finalists showcase the… Read More

Latest drama at Athira: Investor calls for CEO replacement and wants two board seats

A billionaire investor of Athira Pharma is calling for the ouster of the Seattle company’s CEO and nominated himself and… Read More

Ex-Athira Pharma CEO Leen Kawas starts $150M fund with key investors from former company

Leen Kawas, the Seattle biotech exec who resigned as CEO of Athira Pharma after an investigation found she had altered… Read More

Internal memo: Ex-Athira CEO says ‘I should have known better’ after image manipulation investigation

The former CEO of Athira Pharma wrote a letter of contrition addressed to employees on Thursday, after resigning in the… Read More

Ex-Athira Pharma CEO Leen Kawas resigns and leaves board after image manipulation investigation

Leen Kawas has formally resigned as CEO and president of Athira Pharma and is stepping off the board after an… Read More

Athira Pharma extends Alzheimer’s clinical trial, adds new execs after CEO placed on leave

Athira Pharma is advancing its clinical trials in the wake of allegations of image manipulation in papers authored by its… Read More

Biotech firm Athira Pharma hit by class action lawsuits following image manipulation claims

The lawsuits have begun. Barely a week after the CEO of Athira Pharma was placed on temporary leave after allegations… Read More

Athira Pharma CEO Leen Kawas placed on leave, shares sink more than 30%

Athira Pharma CEO Leen Kawas has been placed on temporary leave until the Seattle area biotechnology company completes a review… Read More

Athira Pharma wins $15M grant from National Institute on Aging for trial of Alzheimer’s drug

Seattle-based biotech company Athira Pharma announced a three-year grant totaling $15 million from the National Institute on Aging to support… Read More

Athira Pharma raises $204M in IPO, reaching ‘big milestone’ in fight against Alzheimer’s and other diseases

More than 5 million Americans have Alzheimer’s disease, and the number is projected to rise to nearly 14 million by… Read More

This 35-year-old female CEO is about to crack the glass ceiling, shattering a dismal IPO track record

Leen Kawas is truly a unicorn. The 35-year-old co-founder and CEO of Seattle biotechnology company Athira Pharma would be the… Read More

Wellness tech is helpful, but ‘don’t get too obsessed’ with the numbers, biotech leader says

The number of tools and gadgets aimed at health has skyrocketed in the past few years. That technology can be… Read More

M3 Biotechnology gets another $1.4M in funding, prepares to start clinical trials of leading drug candidate

Seattle-based M3 Biotechnology announced it has received a $1.4 million investment from the Alzheimer’s Drug Discovery Foundation, allowing it to begin… Read More

How a sense of entitlement makes millennials more entrepreneurial

By now, we’re used to hearing complaints about the millennial generation. They’re cocky. They’re entitled. They’re never satisfied. They want… Read More